Biotron Limited Stock Retained Earnings
BITRF Stock | USD 0.06 0.00 0.00% |
Biotron Limited fundamentals help investors to digest information that contributes to Biotron's financial success or failures. It also enables traders to predict the movement of Biotron Pink Sheet. The fundamental analysis module provides a way to measure Biotron's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotron pink sheet.
Biotron |
Biotron Limited Company Retained Earnings Analysis
Biotron's Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current Biotron Retained Earnings | (37 M) |
Most of Biotron's fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotron Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
Competition |
Based on the latest financial disclosure, Biotron Limited has a Retained Earnings of (37 Million). This is 103.97% lower than that of the Healthcare sector and 138.19% lower than that of the Biotechnology industry. The retained earnings for all United States stocks is 100.4% higher than that of the company.
Biotron Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotron's direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Biotron could also be used in its relative valuation, which is a method of valuing Biotron by comparing valuation metrics of similar companies.Biotron is currently under evaluation in retained earnings category among related companies.
Biotron Fundamentals
Return On Equity | -1.12 | |||
Return On Asset | -0.56 | |||
Profit Margin | (1.78) % | |||
Operating Margin | (1.78) % | |||
Current Valuation | 15.31 M | |||
Shares Outstanding | 901.94 M | |||
Shares Owned By Insiders | 14.13 % | |||
Price To Earning | (3.04) X | |||
Price To Book | 23.61 X | |||
Price To Sales | 11.17 X | |||
Revenue | 1.56 M | |||
Gross Profit | 1.56 M | |||
EBITDA | (2.73 M) | |||
Net Income | (2.78 M) | |||
Cash And Equivalents | 1.74 M | |||
Total Debt | 77.24 K | |||
Debt To Equity | 0.07 % | |||
Current Ratio | 2.35 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (2.44 M) | |||
Earnings Per Share | (0) X | |||
Number Of Employees | 10 | |||
Beta | -1.2 | |||
Market Capitalization | 18.67 M | |||
Total Asset | 1.91 M | |||
Retained Earnings | (37 M) | |||
Working Capital | 3 M | |||
Current Asset | 3 M | |||
Net Asset | 1.91 M |
About Biotron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotron Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotron Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biotron
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotron will appreciate offsetting losses from the drop in the long position's value.Moving against Biotron Pink Sheet
0.62 | HD | Home Depot Financial Report 21st of May 2024 | PairCorr |
0.6 | PG | Procter Gamble Financial Report 26th of July 2024 | PairCorr |
0.55 | NVO | Novo Nordisk AS Earnings Call This Week | PairCorr |
0.55 | NONOF | Novo Nordisk AS | PairCorr |
0.47 | JPM | JPMorgan Chase Financial Report 12th of July 2024 | PairCorr |
The ability to find closely correlated positions to Biotron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotron Limited to buy it.
The correlation of Biotron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotron Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotron Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Biotron Pink Sheet analysis
When running Biotron's price analysis, check to measure Biotron's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotron is operating at the current time. Most of Biotron's value examination focuses on studying past and present price action to predict the probability of Biotron's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotron's price. Additionally, you may evaluate how the addition of Biotron to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |